ArticleThoracic cancer2026

Association of Immune-Related Adverse Events and the Efficacy of Immune Checkpoint Inhibitors in Non-Small Cell Lung Cancer: Adjusting for Immortal Time Bias.

Yoshiki Kuwabara et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.